Related Experiment Video
Updated: Jun 3, 2026

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses
Published on: April 4, 2019
Respiratory syncytial virus prevention and therapy: past, present, and future
Melvin Wright1, Giovanni Piedimonte
1Department of Pediatrics and Pediatric Research Institute, West Virginia University School of Medicine, Morgantown, West Virginia 26506-9214, USA.
Insights
Respiratory syncytial virus (RSV) remains a significant global threat to young children, with supportive care being the primary treatment. While a vaccine is still unavailable, passive prophylaxis offers protection for vulnerable infants against this common respiratory pathogen.
Area of Science:
- Pediatrics
- Infectious Diseases
- Virology
Background:
- Respiratory syncytial virus (RSV) is the leading cause of respiratory illness in infants globally.
- Despite decades of research, effective pharmacological treatments and vaccines for RSV remain elusive.
- Supportive care is currently the most effective management strategy for RSV infections.
Purpose of the Study:
- To provide a comprehensive overview of RSV, including its history, microbiology, epidemiology, and clinical features.
- To review current and emerging pharmacologic strategies for managing RSV infections in children.
- To highlight the challenges in treating RSV bronchiolitis in young children.
Main Methods:
- Literature review of historical and current research on RSV.
- Evidence-based analysis of available and investigational pharmacologic therapies.
- Summary of epidemiological data and clinical manifestations of RSV infection.
Main Results:
- RSV continues to be a major pediatric respiratory pathogen worldwide.
- Passive prophylaxis has emerged as a protective measure for high-risk infants.
- The review focuses on clinically relevant treatments, excluding highly experimental options.
Conclusions:
- Effective RSV vaccines and treatments are still under development.
- Understanding RSV's multifaceted aspects is crucial for managing pediatric bronchiolitis.
- Supportive care and passive prophylaxis are key components of current RSV management strategies.
Abstract:
Respiratory syncytial virus (RSV) is the most common respiratory pathogen in infants and young children worldwide. More than 50 years after its discovery, and despite relentless attempts to identify pharmacological therapies to improve the clinical course and outcomes of this disease, the most effective therapy remains supportive care. Although the quest for a safe and effective vaccine remains unsuccessful, pediatricians practicing during the past decade have been able to protect at least the more vulnerable patients with safe and effective passive prophylaxis. This review summarizes the history, microbiology, epidemiology, pathophysiology, and clinical manifestations of this infection in order to provide the reader with the background information necessary to fully appreciate the many challenges presented by the clinical management of young children with bronchiolitis. The last part of this article attempts an evidence-based review of the pharmacologic strategies currently available and those being evaluated, intentionally omitting highly experimental approaches not yet tested in clinical trials and, therefore, not likely to become available in the foreseeable future.
More Related Videos
Related Concept Videos
Respiratory Syncytial Virus Disease
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Common Respiratory Disorders
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...

